Sanofi SA (SNY)
48.28
+0.30
(+0.63%)
USD |
NASDAQ |
Nov 22, 16:00
48.35
+0.07
(+0.14%)
After-Hours: 20:00
Sanofi Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 95.83M |
| June 30, 2023 | -5.686B |
| June 30, 2022 | -5.970B |
| June 30, 2021 | -8.504B |
| June 30, 2020 | -5.949B |
| June 30, 2019 | -3.605B |
| June 30, 2018 | 10.14B |
| June 30, 2017 | -5.713B |
| June 30, 2016 | -4.635B |
| June 30, 2015 | -5.592B |
| June 30, 2014 | -5.951B |
| June 30, 2013 | -4.604B |
| Date | Value |
|---|---|
| June 30, 2012 | -4.200B |
| June 30, 2011 | 14.53B |
| June 30, 2010 | -4.728B |
| June 30, 2009 | 310.88M |
| June 30, 2008 | -5.135B |
| June 30, 2007 | -3.436B |
| June 30, 2006 | -3.902B |
| June 30, 2005 | -3.150B |
| June 30, 2004 | -853.11M |
| June 30, 2003 | -1.540B |
| June 30, 2002 | -724.68M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-8.504B
Minimum
Jun 2021
95.83M
Maximum
Jun 2024
-5.203B
Average
-5.949B
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| AstraZeneca PLC | -4.131B |
| GSK PLC | -1.718B |
| Eli Lilly and Co | 211.30M |
| Novavax Inc | -0.097M |
| Regeneron Pharmaceuticals Inc | -634.00M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | 12.93% |